Expert Advice 20 Mar 2023Nine tips to succeed in pharma-biotech partnerships The question of whether to partner with another company is critical to the long-term development of a biotech. Nonetheless, it… March 20, 2023 - 9 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 30 Jul 2019Belgian Biotech Raises €35M to Develop Eco-Friendly Pesticides The Belgium-based company AgroSavfe has raised a Series C round of €35M to develop an environmentally friendly crop pesticide inspired… July 30, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 4 Sep 2018The EMA Approves the First Nanobody from Ablynx Update: The EMA has officially approved Cablivi for the treatment of adults with acquired thrombotic thrombocytopenic purpura, following its earlier recommendation in… September 4, 2018 - 2 minutesmins - By Editorial Team Share WhatsApp Twitter Linkedin Email
Interview 30 May 2018How to Close a €3.9B Acquisition Deal for Your Biotech Company Ablynx, one of the big giants in the European biotech arena, closed the final stages of its €3.9B acquisition deal… May 30, 2018 - 7 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 29 Jan 2018Another One Gets Snapped Up: Ablynx has been Acquired by Sanofi for €3.9B Sanofi will acquire Ablynx and get its hands on the biotech's exciting Nanobody technology just months after the biotech joined… January 29, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
More News! 9 Jan 2018Ablynx’ Stock Jumps by 60% After Rejecting Acquisition from Novo Nordisk Ablynx has rejected a generous acquisition offer from Novo Nordisk. As a result, its stock has soared and is now worth… January 9, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 9 Jan 2018Happy 2018, Here Are the Top 9 European Biotech Companies To Watch As the 2017 reports roll in, we're already turning our gaze to 2018. These are the top European biotech companies… January 9, 2018 - 5 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
Best in Biotech 18 Dec 2017Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017 Now that we've got the bad news out of the way, we're here to spread some Christmas cheer with the… December 18, 2017 - 9 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Interview 11 Dec 2017Edwin Moses on how Ablynx has made it to the top of European biotech Ablynx CEO Edwin Moses discusses the technology and strategy that has led its company to join the ranks of the… December 11, 2017 - 8 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 5 Dec 2017Europe’s Brightest Stars: The 9 Best Biotech Companies of 2017 Tis the season for Glühwein, Tannenbäume, and lights in Berlin, and Labiotech is celebrating with its year-end lists of the… December 5, 2017 - 6 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 4 Oct 2017Ablynx Launches $175M IPO on Wall Street After Phase III Success Fresh from announcing positive Phase III results, Ablynx has wasted no time in filing a $175M (€148M) IPO to continue… October 4, 2017 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 2 Oct 2017Belgian Biotech Breaks New Ground in Fight Against Life-Threatening Blood Disorder Ablynx has triumphed where others have fallen by receiving positive Phase III results for the treatment of a dangerous blood… October 2, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 20 Jul 2017Sanofi Offers up to €2.4Bn to Belgian Biotech to Develop Nanobodies Ablynx and Sanofi have entered a research collaboration and exclusive licensing agreement for up to eight nanobody candidates for immune… July 20, 2017 - 1 minutemin - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 23 May 2017Merck to Pay Ablynx €15M for Getting a Second Nanobody ready for the Clinic Ablynx is receiving its first milestone payment from a deal with Merck for the development of first-in-class treatments for osteoarthritis.… May 23, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 30 Mar 2017Merck Outsources the Development of its Nanobody for Psoriasis Merck has signed a new agreement with Avillion for its nanobody against psoriasis. Avillion will advance the nanobody from Phase… March 30, 2017 - 3 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
Best in Biotech 15 Mar 2017What are the Best Countries to Recruit Biotech Talents in 2017? Before the “who to recruit” phase, an important question is “where?” We ran through the top countries in which to look… March 15, 2017 - 10 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 12 Jan 2017An Antibody to reduce Hospitalizations of Children starts Phase IIb trials Ablynx has treated its first patient in a new trial targeting RSV infections, the main cause of children hospitalizations. Ablynx,… January 12, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 11 Jan 2017UPDATE: The 5 Hottest European Biotechs in 2017 according to JP Morgan The world's biggest biotech investor conference, hosted by JP Morgan, is now underway in San Francisco, and European companies are… January 11, 2017 - 3 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 9 Aug 2016Ablynx’ Best-In-Class Antibody might not be that ‘Compelling’ to Abbvie Ablynx has disclosed 'compelling' results for its Phase IIb trial in rheumatoid arthritis. But it might have a hard time… August 9, 2016 - 3 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jul 2016Nanobody Phase II Results for Arthritis: Good but not good enough? Ablynx has shown that its candidate for Rheumatoid arthritis could work as a monotherapy, but whether they can convince AbbVie… July 11, 2016 - 3 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email